GAO 510(k) Report May Recommend Splitting Up Class II, Industry Predicts
This article was originally published in The Gray Sheet
Executive Summary
Some device industry veterans predict the pending government report on FDA's 510(k) process will include criticisms of the program and may recommend subdividing Class II moderate-risk devices into two or more new categories
You may also be interested in...
GAO Drafts 510(k) Report; Talk Grows Of Pre-Market Reform Legislation In ’09
After some delay, the Government Accountability Office has drafted a report on FDA's 510(k) submissions program, which some expect will recommend reforms to the Class II, medium-risk category of devices
GAO Drafts 510(k) Report; Talk Grows Of Pre-Market Reform Legislation In ’09
After some delay, the Government Accountability Office has drafted a report on FDA's 510(k) submissions program, which some expect will recommend reforms to the Class II, medium-risk category of devices
Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar
FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis